|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/48 | |
| A61K 9/127 | |||
| A61K 9/14 | |||
| A61K 9/20 | |||
| A61K 9/19 | |||
| A61K 9/28 | |||
| A61K 31/568 |
| (11) | Number of the document | 2846781 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13787438.4 |
| Date of filing the European patent application | 2013-05-09 | |
| (97) | Date of publication of the European application | 2015-03-18 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/040325 |
| Date | 2013-05-09 |
| (87) | Number | WO 2013/170012 |
| Date | 2013-11-14 |
| (30) | Number | Date | Country code |
| 201261644996 P | 2012-05-09 | US |
| (72) |
BETAGERI, Guru, V., US
THIRUCOTE, Ramachandran, US
KADAJJI, Veeran, Gowda, US
|
| (73) |
Western University Of Health Sciences,
309 E. Second Street, Pomona, CA 91766,
US
Tesorx Pharma LLC, 900 Willow Rd. Ste. B, Menlo Park, CA 94025, US |
| (54) | PROLIPOSOMAL TESTOSTERONE FORMULATIONS |
| PROLIPOSOMAL TESTOSTERONE FORMULATIONS |